Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 23.e1-23.e8

  Pignot, Géraldine ^a   Colin, Pierre ^b   Zerbib, Marc ^a   Audenet, François ^c   Soulié, Michel ^d   Hurel, Sophie ^e   Delage, Francky ^f   Irani, Jacques ^g   Descazeaud, Aurélien ^h   Droupy, Stéphane ⁱ   Rozet, François ^j   Phé, Véronique ^k   Ruffion, Alain ^l   Long, Jean Alexandre ^m   Crouzet, Sebastien ^l   Houlgatte, Alain ⁿ   Bigot, Pierre ^o   Guy, Laurent ^p   Faïs, Pierre Olivier ^q   Rouprêt, Morgan ^c  

^a Institut Cochin   (France)

^b UNIV LILLE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^g UNIVERSITÉ DE POITIERS   (France)

^h UNIVERSITY OF LIMOGES   (France)

ⁱ NÎMES UNIVERSITY HOSPITAL   (France)

^j INSTITUT MUTUALISTE MONTSOURIS   (France)

^k FOCH HOSPITAL   (France)

^l UNIVERSITÉ LYON 1   (France)

^m UNIV GRENOBLE ALPES   (France)

ⁿ University of Paris Descartes   (France)

^o UNIVERSITÉ D'ANGERS   (France)

^p UNIVERSITÉ CLERMONT AUVERGNE   (France)

^q ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

more..

Author keywords

Bladder cancer; Prognostic factor; Recurrence; Survival; Upper urinary tract; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METASTASIS FREE SURVIVAL; MIDDLE AGED; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADICAL RESECTION; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; UPPER URINARY TRACT UROTHELIAL CARCINOMA; URETER TUMOR; URINARY TRACT CARCINOMA; VERY ELDERLY; CARCINOMA; CLINICAL TRIAL; DISEASE COURSE; FRANCE; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; NEOPLASMS, MULTIPLE PRIMARY; NEPHRECTOMY; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; TREATMENT OUTCOME; TUMOR RECURRENCE; URETER; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE PROGRESSION; FEMALE; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; NEPHRECTOMY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URETER; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84890796521     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.08.010     Document Type: Article

References (29)

1. van der Poel H.G., Antonini N., van Tinteren H., Horenblas S. Upper urinary tract cancer: location is correlated with prognosis. European Urology 2005, 48:438-444.
2. Mullerad M., Russo P., Golijanin D., et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. Journal of Urology 2004, 172:2177-2181.
3. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005, 65:279-283.
4. Raman J.D., Ng C.K., Boorjian S.A., Vaughan E.D., Sosa R.E., Scherr D.S. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. British Journal of Urology International 2005, 96:1031-1035.
5. Catto J.W., Hartmann A., Stoehr R., et al. Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance. Journal of Urology 2006, 175:2323-2330.
6. Catto J.W., Yates D.R., Rehman I., et al. Behavior of urothelial carcinoma with respect to anatomical location. Journal of Urology 2007, 177:1715-1720.
7. Roupret M. Anatomical location of urothelial carcinomas of the urinary tract leads to perspectives of specific treatment. Future Oncology 2007, 3:595-599.
8. de la Chapelle A. Microsatellite instability. New England Journal of Medicine 2003, 349:209-210.
9. Roupret M., Azzouzi A.R., Cussenot O. Microsatellite instability and transitional cell carcinoma of the upper urinary tract. British Journal of Urology International 2005, 96:489-492.
10. Roupret M., Zigeuner R., Palou J., et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Urology 2011, 59:584-594.
11. Palou J., Rodriguez-Rubio F., Huguet J., et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. Journal of Urology 2005, 174:859-861. [discussion 61].
12. Hall M.C., Womack S., Sagalowsky A.I., Carmody T., Erickstad M.D., Roehrborn C.G. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998, 52:594-601.
13. Novara G., De Marco V., Gottardo F., et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 2007, 110:1715-1722.
14. Sobin L., Gospodarowicz M., Wittekind C. TNM Classification of Malignant Tumours. Urological Tumours. Renal Pelvis and Ureter 2009, Wiley-Blackwell, New York. 7th revised ed.
15. Molinié V. Bladder tumors classification. Progrés en Urologie - Formation Médicale Continue 2006, 16:7-10.
16. Charbit L., Gendreau M.C., Mee S., Cukier J. Tumors of the upper urinary tract: 10 years of experience. Journal of Urology 1991, 146:1243-1246.
17. Zigeuner R.E., Hutterer G., Chromecki T., Rehak P., Langner C. Bladder tumour development after urothelial cell carcinoma of the upper urinary tract is related to primary tumour location. British Journal of Urology International 2006, 98:1181-1186.
18. Chromecki T.F., Cha E.K., Fajkovic H., et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. European Urology 2012, 61:245-253.
19. Miyake H., Hara I., Kamidono S., Eto H. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns. Journal of Urology 2004, 172:1127-1129.
20. Takahashi T., Kakehi Y., Mitsumori K., et al. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors. Journal of Urology 2001, 165:672-677.
21. Hafner C., Knuechel R., Zanardo L., et al. Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 2001, 20:4910-4915.
22. Takahashi T., Habuchi T., Kakehi Y., et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 1998, 58:5835-5841.
23. Azémar M.D., Comperat E., Richard F., Cussenot O., Rouprêt M. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urologic Oncology 2011, 29:130-136.
24. Jones T.D., Wang M., Eble J.N., et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clinical Cancer Research 2005, 11:6512-6519.
25. Novara G., De Marco V., Dalpiaz O., et al. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. British Journal of Urology International 2008, 101:1368-1374.
26. Ouzzane A., Colin P., Xylinas E., et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. European Urology 2011, 60:1258-1265.
27. Akdogan B., Dogan H.S., Eskicorapci S.Y., Sahin A., Erkan I., Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. Journal of Urology 2006, 176:48-52.
28. Rabbani F., Perrotti M., Russo P., Herr H.W. Upper-tract tumors after an initial diagnosis of bladder cancer: argument for long-term surveillance. Journal of Clinical Oncology 2001, 19:94-100.
29. Youssef R.F., Shariat S.F., Lotan Y., et al. Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma. Urology 2011, 77:861-866.